Sign Up
Ready to replace complexity with clarity?
Answer your real world compliance questions (limited time) and save thousands in legal fees and avoided fines.
Automate Compliance TodayUS states A to Z: marijuana, THCA, delta-8, delta-9, delta-10, HHC
State-by-state mapMost read countries: marijuana, CBD and hemp status
All countries on the globeSubstances: status in every state for each one
Compare all substancesFederal hemp redefinition: P.L. 119-103, div. B, sec. 2019
Nov 12, 2026
Applies only to cannabinoids the plant cannot naturally produce.
Dec 11, 2026
The total-THC test, the 0.4 mg per container cap and the exclusion of converted cannabinoids start.
Latest regulatory actions, updated daily
All regulatory actionsHeadlines and the first four sentences are free. Full write-ups, impact reasoning and the archive are for members.
Member · $99/mo
Every rule change, the day it is made.
The price will rise. Join now and $99 a month stays your rate for life.
Become a memberOr read free: every action opens 30 days after it is published. Sign in with email
By topic
Licensing and permitsPackaging and labelingLab testing and QARetail complianceAdvertising and marketingBanking and paymentsTaxesShipping and logisticsTravel and transportLitigationSOPsFor your role
Regulators and agenciesBrands and operatorsRetailers and smoke shopsCultivatorsProcessorsLawyers and complianceInvestorsConsumers and travelersThe Regulator Brief · newsletter
Every rule change that matters, every Monday.
Free: the Monday brief, and every action 30 days after it is published.
Members: the paid weekly, daily alerts and every write-up.
Read by regulators, operators, lawyers and founders.
Cannabis lawyers
Licensed by state. Listings are not endorsements.
By state
Software and services
Compared by fit, never ranked.
Categories
For companies and firms
Be the listing operators and regulators find.
Software and services
Verified, $49/mo: domain-verified badge, your website link, a quote.
Featured, from $399/mo: labeled Featured in your category, monthly release notes.
Lawyers and firms
Claimed, $75/yr: Claimed badge and your firm's website link.
Featured, $199/mo: labeled Featured on your profile.
Claim your companyClaim a lawyer listingPlacements, flat monthly fee
State and country page sponsorshipsExclusive slot on a legality page and its postsRegulator Brief sponsorshipPresenting sponsor or mid-issue banner, free editionMember brief sponsor slotThe paid weekly, read by members onlyFeatured directory placementLabeled Featured in a software categoryCategory sponsorshipOwn one directory category across the sitePaid guest postsLabeled Paid guest post, sponsored linksWrite and partner
Pitch a paid guest postRead guest postsBecome an affiliateSend a tip or correctionContact the teamWho reads it
Regulators at federal, state and county agencies, plus the operators, lawyers and founders they regulate.
Get the media kitSee open placementsSubstances
US states, map and A to ZCountriesFederal hemp 2026: Nov 12 and Dec 11Compound index, every stateTravelling with cannabis or hempMembers get the daily alert email and every full write-up the morning it is published. Every action is free to read 30 days later.
For your role
All news and analysisGuidesAnalysisFAQsTemplates and SOPsCourt filing recapsNews by state and countrySoftware and services: Verified $49/mo, Featured from $399/mo. Lawyers and firms: Claimed $75/yr, Featured $199/mo. Listings are not endorsements.
Regulatory journalism, not legal advice. How we report

Informational only. This article is not legal, tax, or accounting advice.
The federal push to move cannabis to Schedule III remains active but unresolved. The U.S. Department of Justice published its Notice of Proposed Rulemaking (NPRM) to transfer “marijuana” from Schedule I to Schedule III on May 21, 2024 (89 FR 44597). You can read the NPRM on the Federal Register and GovInfo:
DEA subsequently noticed a formal hearing on the proposed rule on August 29, 2024 (89 FR 70148), then postponed the January 2025 hearing pending resolution of a procedural appeal:
As of September 2025, the administrative record remains open and rescheduling is likely according to numerous legal and industry analyses, but the effective date and final text are still uncertain.
What matters now for operators is understanding exactly what Schedule III would and would not change—and how to prepare for the pivotal 280E transition in 2025–2026.
Under 26 U.S.C. § 280E, taxpayers trafficking in controlled substances listed in Schedule I or II cannot take ordinary and necessary business deductions or credits. When cannabis is placed in Schedule III, Section 280E no longer applies to state-legal operators for expenses paid or incurred after the rule’s effective date:
This is the headline change for state-licensed cannabis businesses. The practical impact: materially lower effective tax rates, potentially positive EBITDA-to-cash conversion, improved borrowing capacity, and renewed investor interest.
Rescheduling does not legalize adult-use programs under federal law. Cannabis would remain a controlled substance regulated by the Controlled Substances Act (CSA) and overseen by DEA and FDA. The NPRM stated that if rescheduled, “the regulatory controls applicable to schedule III controlled substances would apply, as appropriate, along with existing marijuana-specific requirements.” See the NPRM summary and hearing notice:
Interstate commerce in state-legal cannabis does not become lawful merely because of rescheduling. Federal authority to control cannabis commerce remains broad (see Gonzales v. Raich, 545 U.S. 1 (2005)):
Rescheduling alone does not create a banking safe harbor. The primary compliance framework remains FinCEN’s 2014 guidance for servicing marijuana-related businesses under the Bank Secrecy Act (BSA), including Suspicious Activity Report (SAR) expectations:
Unless Congress passes a law such as the SAFER Banking Act, banks will still rely on enhanced due diligence and SAR filing frameworks. Some institutions may re-enter the market post-280E, but program risk management will remain intensive until federal law changes.
Moving to Schedule III should make research logistics easier relative to Schedule I (e.g., more suppliers, fewer scheduling hurdles), but DEA registrations, security, recordkeeping, and FDA clinical pathways still apply. DEA’s NPRM indicates that standard Schedule III controls would apply as appropriate, in addition to any marijuana-specific controls or treaty-related requirements:
The U.S. Department of Transportation’s drug testing rules hinge on the HHS Mandatory Guidelines and 49 CFR Part 40—not the CSA schedules alone. As of 2025, HHS maintains marijuana analytes on authorized testing panels, and the guidelines remain in force through at least July 7, 2025, absent further updates:
Bottom line: safety‑sensitive employees and many federal contractors will still be subject to THC testing until DOT/HHS revise their rules. Employers should continue to align policies with DOT/HHS and the Drug‑Free Workplace Act.
The most pressing “when” question for cannabis finance leaders is how 280E relief will flow through 2025 returns if a final rule takes effect mid‑year. While the IRS has not issued rescheduling‑specific transition guidance as of publication, core tax principles provide a roadmap:
Because this is a complex intersection of tax accounting and administrative law, build internal memos with your CPA/tax counsel documenting positions, calculations, and supporting authorities for 2025 filings.
With 280E relief on the horizon, CFOs should execute a structured transition plan.
Rescheduling does not change your day‑to‑day state compliance obligations. Continue to operate as if nothing changed at the state level unless regulators say otherwise:
Use this list to drive internal readiness while the DEA process unfolds.
Governance and Planning
Tax and Accounting
Banking and Treasury
Operations and HR
Commercial
Regulatory Monitoring
For industry analysis on the limits of rescheduling and operational implications, see:
Need help translating federal rescheduling into a state‑by‑state compliance and tax action plan? Visit https://cannabisregulations.ai/ for tailored updates, alerts, and tools to keep your team audit‑ready.